Page 4 - Benchmark Research News Today

VaxCorps Announces Massive Expansion of Vaccine Research Network Share Article VaxCorps, a U.S. and Canada based integrated research organization specializing in the conduct of vaccine trials, today announced the expansion to the network of three new partners—Coastal Carolina Research Center, Elligo Health Research, and Javara Research—adding additional vaccine capabilities and capacity required to support its rapid business growth. AUSTIN, Texas (PRWEB) ...

With millions of adults fully vaccinated, many families are wondering when their children will be able to receive the same protection.Benchmark Research is currently looking for participants in the Sacramento area to join their trial for the Novavax pediatric vaccine.The company says its important to have a diverse pool of vaccine trial participants. “We have to demonstrate to the authorities that it will induce a good immune response. That this younger group won’t have a more signific...

Local clinical company Benchmark Research is looking for up to 250 volunteers for a trial with the Medicago vaccine.

Despite the Covid-19 health crisis impacting significantly on the lifting industry, Lifting Equipment Engineers Association (LEEA) Sector Benchmark Research reveals optimism for the post-pandemic future

Plant-based COVID-19 vaccine trial needs volunteers in our area Dr. Brian Ward said people confuse the plant with nicotine tobacco but it is actually a distant cousin. Author: Daranesha Herron (KVUE) Updated: 7:15 PM CDT April 1, 2021 AUSTIN, Texas — A plant-based COVID-19 vaccine is inching closer to emergency use authorization by starting trials around the country, including Austin.  Three COVID-19 vaccines received emergency use authorization in the U.S., a...

CRIO : Secures Series A Financing to Accelerate Growth and Platform Development 03/11/2021 | 10:26am EDT Send by mail : Message : Required fields BOSTON, March 11, 2021 /PRNewswire/ -- Clinical Research IO (CRIO), a Boston-based technology firm offering clinical research sponsors and sites a platform to streamline clinical trials, announced the completion of a $3.5 million Series A round led by Rally Ventures.  The round allows CRIO to expand its product and engineering teams to develop the n...

CRIO Secures Series A Financing to Accelerate Growth and Platform Development News provided by Share this article Share this article BOSTON, March 11, 2021 /PRNewswire/ -- Clinical Research IO (CRIO), a Boston-based technology firm offering clinical research sponsors and sites a platform to streamline clinical trials, announced the completion of a $3.5 million Series A round led by Rally Ventures.  The round allows CRIO to expand its product and engineering teams to develop the next wave of pr...

Listen: Mark Lacy, CEO of Benchmark Research talks about Johnson & Johnson covid vaccine trials taking place in Sacramento and how you can participate.

Johnson & Johnson COVID vaccine trials are underway in Austin. 

Johnson & Johnson COVID vaccine trials are underway in Austin.